Your browser doesn't support javascript.
loading
Pharmacodynamics of Pre-Operative PD1 checkpoint blockade and receptor activator of NFkB ligand (RANKL) inhibition in non-small cell lung cancer (NSCLC): study protocol for a multicentre, open-label, phase 1B/2, translational trial (POPCORN).
Ahern, Elizabeth; Cubitt, Annette; Ballard, Emma; Teng, Michele W L; Dougall, William C; Smyth, Mark J; Godbolt, David; Naidoo, Rishendran; Goldrick, Amanda; Hughes, Brett G M.
Afiliación
  • Ahern E; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. elizabeth.ahern2@health.qld.gov.au.
  • Cubitt A; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia. elizabeth.ahern2@health.qld.gov.au.
  • Ballard E; School of Medicine, University of Queensland, Herston, Queensland, Australia. elizabeth.ahern2@health.qld.gov.au.
  • Teng MWL; Cancer Care Services, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia. elizabeth.ahern2@health.qld.gov.au.
  • Dougall WC; Cancer Care Services, Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.
  • Smyth MJ; Statistics Unit, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Godbolt D; Cancer Immunoregulation and Immunotherapy Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Naidoo R; School of Medicine, University of Queensland, Herston, Queensland, Australia.
  • Goldrick A; Immunology in Cancer and Infection Laboratory, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.
  • Hughes BGM; Immuno-Oncology Discovery Laboratory, QIMR Berghofer Medical Research Institute, Herston,, Queensland, Australia.
Trials ; 20(1): 753, 2019 Dec 19.
Article en En | MEDLINE | ID: mdl-31856909
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Terapia Neoadyuvante / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2019 Tipo del documento: Article País de afiliación: Australia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Asunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Carcinoma de Pulmón de Células no Pequeñas / Terapia Neoadyuvante / Antineoplásicos Inmunológicos / Neoplasias Pulmonares Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Female / Humans / Male Idioma: En Revista: Trials Asunto de la revista: MEDICINA / TERAPEUTICA Año: 2019 Tipo del documento: Article País de afiliación: Australia